IP Library Patent Application 11950914
Patent Application
App. No. 11/950,914

Synthetic Methods and Intermediates for Stereoisomeric Compounds Useful for the Treatment of Gastrointestinal and Central Nervous System Disorders

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/950,914
Abstract

The subject invention provides methods and/or processes for making stereoisomeric compounds of formula (X): wherein the variables are as defined herein, and compositions for the safe and effective treatment of various gastrointestinal disorders including, but not limited to, gastroparesis, gastroesophageal reflux and related conditions. The compounds of the subject invention are also useful in treating a variety of conditions involving the central nervous system.

Claims (16)

1 .- 18 . (canceled)

19 . A compound of formula II′

or a salt thereof, wherein X 1 is a nitrogen protecting group and X 2 is selected from the group consisting of hydrogen and a nitrogen protecting group, and R is (C 1 -C 8 )alkyl.

20 . (canceled)

21 . A compound of formula III′

or a salt thereof, wherein X 1 is a nitrogen protecting group and X 2 is selected from the group consisting of hydrogen and a nitrogen protecting group.

22 .- 24 . (canceled)

25 . A compound of formula III″

or a salt thereof, wherein X 1 is a nitrogen protecting group and X 2 is selected from the group consisting of hydrogen and a nitrogen protecting group.

26 . (canceled)

27 . A compound of formula IV′

or a salt thereof, wherein R′ is (C 1 -C 8 )alkyl (preferably ethyl), and X 1 is a nitrogen protecting group and X 2 is selected from the group consisting of hydrogen and a nitrogen protecting group.

28 .- 30 . (canceled)

31 . A compound of formula V′

or a salt thereof, wherein X 1 is a nitrogen protecting group and X 2 is selected from the group consisting of hydrogen and a nitrogen protecting group.

32 .- 36 . (canceled)

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2008
From: BY, KOLBOT; YEH, JB; PANG, PONNY
To: ARYX THERAPEUTICS, INC.
Reel/Frame 021966/0555 →